|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ricketts CJ, De Cubas AA, Fan H, Smith CC,
Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, et al:
The cancer genome atlas comprehensive molecular characterization of
renal cell carcinoma. Cell Rep. 23:313–326.e5. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Singh D: Current updates and future
perspectives on the management of renal cell carcinoma. Life Sci.
264:1186322021. View Article : Google Scholar
|
|
4
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ricketts CJ, De Cubas AA, Fan H, Smith CC,
Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, et al:
The cancer genome atlas comprehensive molecular characterization of
renal cell carcinoma. Cell Rep. 23:36982018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mitchell TJ, Turajlic S, Rowan A, Nicol D,
Farmery JHR, O'Brien T, Martincorena I, Tarpey P, Angelopoulos N,
Yates LR, et al: Timing the landmark events in the evolution of
clear cell renal cell cancer: TRACERx renal. Cell. 173:611–623.e17.
2018. View Article : Google Scholar
|
|
7
|
Hosono K, Sasaki T, Minoshima S and
Shimizu N: Identification and characterization of a novel gene
family YPEL in a wide spectrum of eukaryotic species. Gene.
340:31–43. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roxström-Lindquist K and Faye I: The
Drosophila gene yippee reveals a novel family of putative zinc
binding proteins highly conserved among eukaryotes. Insect Mol
Biol. 10:77–86. 2001. View Article : Google Scholar
|
|
9
|
Hosono K, Noda S, Shimizu A, Nakanishi N,
Ohtsubo M, Shimizu N and Minoshima S: YPEL5 protein of the YPEL
gene family is involved in the cell cycle progression by
interacting with two distinct proteins RanBPM and RanBP10.
Genomics. 96:102–111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Truong L, Zheng YM, Song T, Tang Y and
Wang YX: Potential important roles and signaling mechanisms of
YPEL4 in pulmonary diseases. Clin Transl Med. 7:162018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oki K, Plonczynski MW, Gomez-Sanchez EP
and Gomez-Sanchez CE: YPEL4 modulates HAC15 adrenal cell
proliferation and is associated with tumor diameter. Mol Cell
Endocrinol. 434:93–98. 2016. View Article : Google Scholar
|
|
12
|
Berberich SJ, Todd A and Tuttle R: Why
YPEL3 represents a novel tumor suppressor. Front Biosci (Landmark
Ed). 16:1746–1751. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li S, Sun MY and Su X: MiR-885-5p promotes
gastric cancer proliferation and invasion through regulating YPEL1.
Eur Rev Med Pharmacol Sci. 23:7913–7919. 2019.
|
|
14
|
Abiatari I, Kiladze M, Kerkadze V, Friess
H and Kleeff J: Expression of YPEL1 in pancreatic cancer cell lines
and tissues. Georgian Med News. 60–62. 2009.
|
|
15
|
Wu X: Up-regulation of YPEL1 and YPEL5 and
down-regulation of ITGA2 in erlotinib-treated EGFR-mutant non-small
cell lung cancer: A bioinformatic analysis. Gene. 643:74–82. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tuttle R, Simon M, Hitch DC, Maiorano JN,
Hellan M, Ouellette J, Termuhlen P and Berberich SJ:
Senescence-associated gene YPEL3 is downregulated in human colon
tumors. Ann Surg Oncol. 18:1791–1796. 2011. View Article : Google Scholar
|
|
17
|
Zhang J, Wen X, Ren XY, Li YQ, Tang XR,
Wang YQ, He QM, Yang XJ, Sun Y, Liu N and Ma J: YPEL3 suppresses
epithelial-mesenchymal transition and metastasis of nasopharyngeal
carcinoma cells through the Wnt/β-catenin signaling pathway. J Exp
Clin Cancer Res. 35:1092016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou D, Tang W, Xu Y, Xu Y, Xu B, Fu S,
Wang Y, Chen F, Chen Y, Han Y and Wang G: METTL3/YTHDF2 m6A axis
accelerates colorectal carcinogenesis through epigenetically
suppressing YPEL5. Mol Oncol. 15:2172–2184. 2021. View Article : Google Scholar
|
|
19
|
Kelemen LE, Wang X, Fredericksen ZS,
Pankratz VS, Pharoah PD, Ahmed S, Dunning AM, Easton DF, Vierkant
RA, Cerhan JR, et al: Genetic variation in the chromosome 17q23
amplicon and breast cancer risk. Cancer Epidemiol Biomarkers Prev.
18:1864–1868. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoshihara K, Shahmoradgoli M, Martínez E,
Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW,
Levine DA, et al: Inferring tumour purity and stromal and immune
cell admixture from expression data. Nat Commun. 4:26122013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Newman AM, Liu CL, Green MR, Gentles AJ,
Feng W, Xu Y, Hoang CD, Diehn M and Alizadeh AA: Robust enumeration
of cell subsets from tissue expression profiles. Nat Methods.
12:453–457. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Velusamy T, Palanisamy N, Kalyana-Sundaram
S, Sahasrabuddhe AA, Maher CA, Robinson DR, Bahler DW, Cornell TT,
Wilson TE, Lim MS, et al: Recurrent reciprocal RNA chimera
involving YPEL5 and PPP1CB in chronic lymphocytic leukemia. Proc
Natl Acad Sci USA. 110:3035–3040. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kelley KD, Miller KR, Todd A, Kelley AR,
Tuttle R and Berberich SJ: YPEL3, a p53-regulated gene that induces
cellular senescence. Cancer Res. 70:3566–3575. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Farlie P, Reid C, Wilcox S, Peeters J,
Reed G and Newgreen D: Ypel1: A novel nuclear protein that induces
an epithelial-like morphology in fibroblasts. Genes Cells.
6:619–629. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:(Database Issue).
D991–D995. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Braun DA, Hou Y, Bakouny Z, Ficial M,
Sant' Angelo M, Forman J, Ross-Macdonald P, Berger AC, Jegede OA,
Elagina L, et al: Interplay of somatic alterations and immune
infiltration modulates response to PD-1 blockade in advanced clear
cell renal cell carcinoma. Nat Med. 26:909–918. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim MC, Jin Z, Kolb R, Borcherding N,
Chatzkel JA, Falzarano SM and Zhang W: Updates on immunotherapy and
immune landscape in renal clear cell carcinoma. Cancers (Basel).
13:58562021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cao Y, Jiao N, Sun T, Ma Y, Zhang X, Chen
H, Hong J and Zhang Y: CXCL11 correlates with antitumor immunity
and an improved prognosis in colon cancer. Front Cell Dev Biol.
9:6462522021. View Article : Google Scholar
|
